An Olmesartan Medoxomil-Based Treatment Algorithm is Effective in Achieving 24-Hour BP Control in Patients with Type 2 Diabetes Mellitus, Regardless of Age, Race, Sex, or Severity of Hypertension: Subgroup Analysis of the BENIFICIARY Study

Background Hypertension often occurs concomitantly with diabetes mellitus, such that >50% of adults with type 2 diabetes have hypertension. These individuals are at a greater risk of developing renal and cardiovascular disease. The currently recommended BP goal of

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of cardiovascular drugs : drugs, devices, and other interventions devices, and other interventions, 2010-01, Vol.10 (5), p.289-303
Hauptverfasser:	Neutel, Joel M., Kereiakes, Dean J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Factors Aged Algorithms Antihypertensive Agents - therapeutic use Blood pressure Blood Pressure - drug effects Cardiology Control Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - physiopathology Diabetics Female Health aspects Humans Hypertension - drug therapy Hypertension - ethnology Imidazoles - therapeutic use Male Medicine Medicine & Public Health Middle Aged Olmesartan Medoxomil Original Research Article Pharmacology/Toxicology Pharmacotherapy Prospective Studies Sex Characteristics Tetrazoles - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background Hypertension often occurs concomitantly with diabetes mellitus, such that >50% of adults with type 2 diabetes have hypertension. These individuals are at a greater risk of developing renal and cardiovascular disease. The currently recommended BP goal of
ISSN:	1175-3277 1179-187X
DOI:	10.2165/11584690-000000000-00000